Following the results announcement, ICRA shares traded at ₹5,469.90 on May 22, 2026, registering a modest 0.44% gain. The stock remains significantly below its 52-week high of ₹7,135.35, down 23.34%, reflecting investor concerns about valuation and growth momentum in the capital markets sector.
The quarter's performance presents a paradox: whilst sequential growth appears impressive, the underlying year-on-year trends and five-year growth metrics suggest a maturing business facing structural headwinds. With net sales growing at just 12.88% annually over the past five years and operating profit expanding at 17.88%, ICRA's growth profile falls short of expectations for a company trading at 28 times trailing twelve-month earnings.
| Quarter | Revenue (₹ Cr) | QoQ Change | Net Profit (₹ Cr) | QoQ Change | Operating Margin |
|---|---|---|---|---|---|
| Mar'26 | 174.85 | +6.88% | 52.45 | +35.11% | 39.78% |
| Dec'25 | 163.59 | +19.78% | 38.82 | -18.80% | 34.96% |
| Sep'25 | 136.58 | +9.71% | 47.81 | +12.65% | 35.54% |
| Jun'25 | 124.49 | -8.60% | 42.44 | -23.86% | 31.92% |
| Mar'25 | 136.21 | +12.69% | 55.74 | +32.62% | 43.43% |
| Dec'24 | 120.87 | -4.16% | 42.03 | +14.46% | 34.88% |
| Sep'24 | 126.12 | — | 36.72 | — | 32.71% |
Financial Performance: Revenue Strength Offset by Margin Volatility
ICRA's Q4 FY26 revenue of ₹174.85 crores represents the highest quarterly sales figure in the company's recent history, marking a 28.37% year-on-year increase from ₹136.21 crores in Q4 FY25. This robust top-line expansion was driven by increased rating volumes and higher realisations across corporate and financial sector clients. Sequential growth of 6.88% from Q3 FY26's ₹163.59 crores indicates sustained business momentum entering the new fiscal year.
However, profitability metrics reveal a more nuanced picture. Operating profit (excluding other income) stood at ₹69.55 crores in Q4 FY26, translating to a 39.78% margin—an improvement from Q3 FY26's 34.96% but still below the 43.43% achieved in Q4 FY25. This margin compression of 365 basis points year-on-year stems primarily from elevated employee costs, which surged to ₹84.27 crores in Q4 FY26 from ₹61.14 crores in the year-ago quarter, reflecting aggressive talent acquisition and retention strategies in a competitive labour market.
The profit after tax margin of 30.13% in Q4 FY26 represents a significant deterioration from 41.11% in Q4 FY25, with the 1,098 basis point compression reflecting both operational margin pressure and reduced contribution from other income. Other income declined to ₹14.18 crores in Q4 FY26 from ₹20.62 crores in Q4 FY25, impacting overall profitability despite the company's substantial treasury management capabilities.
The tax rate remained relatively stable at 27.62% in Q4 FY26 compared to 24.40% in Q4 FY25, with the marginal increase reflecting normalisation after previous quarters' tax optimisation benefits. Depreciation charges jumped to ₹10.00 crores from ₹4.48 crores year-on-year, indicating capital investments in technology infrastructure and office facilities.
Margin Pressure Alert
Whilst revenue growth remains robust at 28.37% year-on-year, operating margins have compressed by 365 basis points to 39.78%, primarily driven by a 37.80% increase in employee costs. This trend warrants close monitoring as it suggests potential challenges in maintaining pricing power or controlling operational expenses in an increasingly competitive rating industry landscape.
Operational Quality: Strong Returns Despite Growth Constraints
ICRA's operational quality metrics present a compelling picture of capital efficiency, with the company delivering an exceptional return on capital employed (ROCE) of 5,394.38% in the latest period. This extraordinary figure stems from the asset-light nature of the rating business, which requires minimal fixed capital deployment. The five-year average ROCE of 683.25% underscores the structural attractiveness of ICRA's business model, where intellectual capital and brand reputation drive value creation rather than physical assets.
Return on equity (ROE) stood at 17.29% for the latest period, representing solid capital efficiency that reflects the company's ability to generate meaningful returns for shareholders. The five-year average ROE of 15.18% positions ICRA favourably within the financial services sector, though it trails some higher-growth peers. This metric indicates that ICRA efficiently converts shareholder capital into profits, a strength particularly valuable given the company's minimal leverage and debt-free balance sheet.
The company's balance sheet reveals remarkable financial strength, with shareholder funds of ₹1,053.23 crores as of March 2025 and negligible long-term debt of just ₹0.63 crores. This translates to a net debt-to-equity ratio of -1.00, effectively making ICRA a net cash company with substantial liquid resources. Current assets of ₹1,128.12 crores as of March 2025 provide ample liquidity to support operations and strategic initiatives, whilst investments stood at ₹1.25 crores, down significantly from ₹390.20 crores in the previous year, suggesting strategic reallocation of capital.
Capital Efficiency Highlight
ICRA's exceptional ROCE of 5,394.38% and healthy ROE of 17.29% underscore the inherent attractiveness of the credit rating business model. With virtually no debt (net debt-to-equity of -1.00) and strong interest coverage of 46.89 times, the company maintains fortress-like financial stability. However, the modest five-year sales growth of 12.88% suggests limited reinvestment opportunities for this excess capital, raising questions about optimal capital allocation strategies.
Operating cash flow generation remains robust, with ₹144.00 crores generated in FY25, up from ₹107.00 crores in FY24. This strong cash generation capability, combined with minimal capital expenditure requirements, has enabled ICRA to maintain a dividend payout ratio of 63.88%, returning substantial value to shareholders whilst retaining adequate capital for growth initiatives. The company's closing cash balance of ₹34.00 crores in FY25 provides operational flexibility, though the decline from peak levels warrants monitoring.
Industry Context: Navigating Cyclical Headwinds
The capital markets sector in India has experienced significant volatility over the past year, with regulatory changes, market corrections, and shifting investor sentiment impacting transaction volumes and rating activity. ICRA operates in a duopolistic market structure alongside CRISIL, with both players commanding significant market share in the domestic credit rating space. The company's positioning as the second-largest rating agency provides competitive advantages through scale economies and brand recognition, though it also exposes the business to sector-wide cyclicality.
Recent quarters have witnessed fluctuating demand patterns, with corporate debt issuances showing uneven momentum across sectors. The financial services sector, which contributes meaningfully to ICRA's revenue mix, has seen moderated growth as regulatory tightening and risk aversion have tempered lending expansion. Infrastructure and manufacturing sectors have provided some offset through project financing activity, though overall market sentiment remains cautious.
The competitive landscape has intensified with smaller rating agencies attempting to gain market share through aggressive pricing strategies. However, ICRA's established reputation and regulatory standing provide meaningful barriers to entry, with institutional clients typically preferring ratings from established players for their debt issuances. The company's collaboration with Moody's Investors Service, which holds a 51.87% promoter stake, provides access to global best practices and analytical frameworks, enhancing credibility with international investors.
| Company | P/E (TTM) | P/BV | ROE (%) | Div Yield (%) | Market Cap (₹ Cr) |
|---|---|---|---|---|---|
| ICRA | 27.93 | 4.87 | 15.18 | 1.09 | 5,279 |
| KFin Technologies | 40.60 | 8.57 | 22.20 | — | — |
| UTI AMC | 24.76 | 2.68 | 14.06 | 5.09 | — |
| Indian Energy Exchange | 22.87 | 8.26 | 38.31 | 2.77 | — |
| Prudent Corporate | 50.06 | 12.59 | 30.07 | 0.09 | — |
| IIFL Capital | 18.97 | 3.47 | 23.96 | 0.88 | — |
Peer Comparison: Moderate Valuation with Below-Average Returns
ICRA's valuation metrics position the company in the middle of its peer group within the capital markets sector. At a price-to-earnings ratio of 27.93 times, ICRA trades at a discount to the broader sector average of approximately 31 times, reflecting investor concerns about growth momentum. This valuation appears reasonable when compared to peers like KFin Technologies (40.60x) and Prudent Corporate (50.06x), though it commands a premium over IIFL Capital (18.97x) and Indian Energy Exchange (22.87x).
The price-to-book value multiple of 4.87 times sits comfortably in the mid-range of peers, significantly below KFin Technologies (8.57x), Indian Energy Exchange (8.26x), and Prudent Corporate (12.59x), whilst exceeding UTI AMC (2.68x) and IIFL Capital (3.47x). This moderate valuation reflects ICRA's established market position and quality franchise, though the premium appears justified only if the company can demonstrate accelerated growth in coming quarters.
However, ICRA's return on equity of 15.18% lags most peers substantially, with Indian Energy Exchange delivering 38.31%, Prudent Corporate achieving 30.07%, IIFL Capital generating 23.96%, and KFin Technologies posting 22.20%. Only UTI AMC, at 14.06%, trails ICRA's profitability metrics. This below-average return profile raises questions about whether ICRA's valuation premium is sustainable, particularly given the company's modest growth trajectory.
The dividend yield of 1.09% appears uncompetitive compared to UTI AMC's 5.09% and Indian Energy Exchange's 2.77%, though it exceeds the minimal yields offered by Prudent Corporate (0.09%) and IIFL Capital (0.88%). ICRA's latest dividend of ₹60 per share, distributed in July 2025, reflects the company's commitment to shareholder returns, though the modest yield suggests limited income appeal for dividend-focused investors at current price levels.
Valuation Analysis: Premium Pricing for Modest Growth
At the current market price of ₹5,469.90, ICRA trades at 28 times trailing twelve-month earnings, representing a significant premium to its historical averages and appearing expensive relative to the company's growth profile. The valuation has been classified as "Very Expensive" since August 2020, with brief periods of moderation, indicating persistent investor concerns about the sustainability of current multiples given the business's maturation.
The enterprise value-to-EBITDA multiple of 20.60 times and EV-to-EBIT of 23.18 times further underscore the premium valuation, particularly when considered against the company's five-year operating profit growth of just 17.88% annually. The EV-to-sales ratio of 7.52 times reflects investor willingness to pay substantial premiums for ICRA's asset-light, high-margin business model, though such multiples typically require sustained double-digit growth to justify.
The PEG ratio of 1.57 suggests moderate overvaluation when considering the company's growth rate, with values above 1.0 typically indicating that the stock price has outpaced earnings growth expectations. Given ICRA's five-year sales CAGR of 12.88%, the current valuation appears to discount significant future acceleration that may prove challenging to achieve given market maturity and competitive dynamics.
The stock's 52-week range of ₹4,905.15 to ₹7,135.35 illustrates substantial volatility, with the current price sitting 23.34% below the peak and 11.51% above the trough. This wide trading range reflects shifting investor sentiment about growth prospects and sector dynamics, with the recent weakness suggesting diminished confidence in near-term catalysts. The book value per share of ₹1,091.29 provides a valuation floor, though the 5x premium to book value leaves limited downside protection in adverse scenarios.
Shareholding Pattern: Stable Promoter Base, Shifting Institutional Mix
ICRA's shareholding structure has remained remarkably stable over recent quarters, with promoter holding unchanged at 51.87% across the past five reporting periods. This consistent stake, held primarily by Moody's Investment Company India Private Limited (31.66%) and Moody's Singapore Pte Ltd (20.20%), provides governance stability and strategic alignment with the global Moody's franchise. The absence of promoter pledging (0%) further reinforces confidence in the company's financial position and management commitment.
| Shareholder Category | Mar'26 | Dec'25 | Sep'25 | Jun'25 | QoQ Change |
|---|---|---|---|---|---|
| Promoter | 51.87% | 51.87% | 51.87% | 51.87% | 0.00% |
| FII | 7.92% | 7.25% | 6.87% | 8.66% | +0.67% |
| Mutual Funds | 19.84% | 20.66% | 19.73% | 17.56% | -0.82% |
| Insurance | 2.48% | 2.49% | 2.74% | 2.84% | -0.01% |
| Other DII | 2.19% | 2.40% | 3.68% | 3.98% | -0.21% |
| Non-Institutional | 15.69% | 15.35% | 15.11% | 15.10% | +0.34% |
Institutional shareholding patterns reveal nuanced shifts in investor sentiment. Foreign institutional investors increased their stake to 7.92% in March 2026 from 7.25% in December 2025, marking the second consecutive quarter of accumulation after significant reduction in September 2025. This uptick suggests renewed international interest, though the overall FII holding remains below the 8.78% level from March 2025, indicating cautious positioning.
Mutual fund holdings declined marginally to 19.84% in March 2026 from 20.66% in December 2025, reversing the previous quarter's increase. Despite this recent reduction, mutual funds remain the largest institutional shareholder category with 10 funds holding positions, suggesting continued domestic institutional confidence albeit with some profit-booking at elevated valuations. The cumulative increase from 17.33% in March 2025 to current levels indicates net accumulation over the full year.
Insurance company holdings have trended steadily downward, declining to 2.48% in March 2026 from 2.87% in March 2025, reflecting a consistent reduction pattern across quarters. Similarly, other domestic institutional investors reduced their stake to 2.19% from 3.97% over the same period, suggesting a strategic reallocation away from ICRA by certain institutional categories. The non-institutional shareholding of 15.69% has remained relatively stable, indicating retail investor interest despite the stock's volatile performance.
Stock Performance: Underperformance Amid Sector Weakness
ICRA's stock has delivered disappointing returns across most timeframes, with the one-year performance showing a decline of 13.94% compared to the Sensex's 6.57% fall, resulting in negative alpha of 7.37 percentage points. This underperformance reflects both company-specific concerns about growth deceleration and broader sector weakness in capital markets stocks, which have faced headwinds from regulatory changes and reduced market activity.
| Period | ICRA Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | +1.20% | +0.53% | +0.67% |
| 1 Month | +1.00% | -3.67% | +4.67% |
| 3 Months | -4.14% | -8.67% | +4.53% |
| 6 Months | -9.59% | -11.26% | +1.67% |
| YTD | -9.84% | -11.25% | +1.41% |
| 1 Year | -13.94% | -6.57% | -7.37% |
| 3 Years | +13.90% | +22.06% | -8.16% |
| 5 Years | +73.17% | +49.65% | +23.52% |
The year-to-date performance shows a 9.84% decline, marginally outperforming the Sensex's 11.25% fall with positive alpha of 1.41 percentage points. This relative outperformance in a weak market environment suggests some defensive characteristics, though the absolute losses remain concerning for investors. The six-month return of -9.59% similarly shows modest outperformance against the benchmark's -11.26% decline.
Recent momentum indicators provide mixed signals, with the one-month return of +1.00% outperforming the Sensex's -3.67% decline by 4.67 percentage points, suggesting potential stabilisation. The one-week gain of 1.20% further supports this nascent recovery narrative, though the stock remains well below its 200-day moving average of ₹5,971.84, indicating an intact longer-term downtrend.
Longer-term performance metrics reveal more favourable trends, with the five-year return of +73.17% significantly outpacing the Sensex's +49.65% gain, generating positive alpha of 23.52 percentage points. This longer-term outperformance reflects ICRA's fundamental business quality and market positioning during the preceding growth phase, though recent deceleration has eroded much of this relative advantage. The three-year return of +13.90% underperforms the Sensex's +22.06% by 8.16 percentage points, highlighting the inflection point where growth momentum began to wane.
Technical indicators paint a cautious picture, with the stock classified as "Mildly Bearish" as of May 22, 2026. The stock trades below all key moving averages—5-day (₹5,411.03), 20-day (₹5,403.35), 50-day (₹5,334.71), 100-day (₹5,655.57), and 200-day (₹5,971.84)—suggesting persistent selling pressure and lack of conviction among technical traders. The beta of 1.35 indicates higher volatility than the broader market, with the stock classified as "High Beta," amplifying both upside potential and downside risk.
Investment Thesis: Quality Business Facing Growth Headwinds
ICRA presents a paradoxical investment case: exceptional capital efficiency and fortress balance sheet strength juxtaposed against modest growth and premium valuation. The company's quality credentials remain intact, with a "Good" quality grade reflecting strong long-term financial performance, zero debt, exceptional return on capital employed, and consistent profitability. The asset-light business model generates substantial cash flows with minimal capital requirements, whilst the Moody's parentage provides strategic advantages and global credibility.
However, multiple concerning factors constrain the investment appeal at current valuations. The five-year sales growth of 12.88% and operating profit expansion of 17.88% appear insufficient to justify a 28x earnings multiple, particularly when margins face compression from rising employee costs. The year-on-year profit decline of 5.90% in Q4 FY26, despite strong revenue growth, highlights operational leverage challenges and raises questions about the sustainability of profitability expansion.
Key Strengths
- Exceptional ROCE of 5,394.38% demonstrates capital efficiency
- Zero debt with net cash position provides financial flexibility
- Stable 51.87% promoter holding by Moody's ensures governance quality
- Duopolistic market structure with CRISIL limits competitive intensity
- Strong Q4 FY26 revenue growth of 28.37% year-on-year
- Consistent dividend payer with 63.88% payout ratio
- High institutional holding of 32.44% validates investment thesis
Key Concerns
- Net profit declined 5.90% year-on-year despite revenue growth
- Operating margin compressed 365 basis points to 39.78%
- Modest five-year sales CAGR of 12.88% suggests maturation
- ROE of 15.18% lags most capital markets peers significantly
- Premium valuation at 28x earnings appears expensive for growth profile
- Stock underperformed Sensex by 7.37% over past year
- Mildly bearish technical trend with stock below all moving averages
The valuation classification of "Very Expensive" since August 2020 reflects persistent concerns about sustainability of premium multiples. With the stock trading below all key moving averages and exhibiting a mildly bearish technical trend, near-term price momentum appears unfavourable. The one-year underperformance of 13.94% versus the Sensex's 6.57% decline underscores investor scepticism about the company's ability to reaccelerate growth.
Outlook: Monitoring Points for Trend Reversal
The investment outlook for ICRA hinges on the company's ability to demonstrate sustained revenue acceleration whilst controlling cost inflation and margin compression. Several key factors will determine whether the current challenges represent temporary headwinds or structural impediments to value creation.
Positive Catalysts
- Sustained revenue growth above 20% for multiple quarters
- Operating margin stabilisation above 40% through operating leverage
- Market share gains in high-growth segments like structured finance
- Acceleration in corporate debt issuances driving rating volumes
- Strategic initiatives to diversify revenue streams beyond traditional ratings
Red Flags
- Further margin compression below 35% indicating pricing pressure
- Consecutive quarters of year-on-year profit decline
- Market share erosion to smaller competitors on pricing grounds
- Significant reduction in mutual fund holdings below 15%
- Inability to grow revenues faster than 15% annually
For existing shareholders, the decision to hold or exit depends on conviction in management's ability to navigate the current growth deceleration whilst maintaining operational efficiency. The company's quality fundamentals and market positioning provide some downside protection, though the premium valuation leaves limited margin of safety. Fresh investors should await clearer evidence of growth reacceleration and margin stabilisation before initiating positions, particularly given the mildly bearish technical setup and unfavourable near-term momentum indicators.
The Verdict: Quality Business at Premium Valuation Facing Growth Challenges
Score: 48/100
For Fresh Investors: Avoid initiating positions at current valuations. The premium 28x earnings multiple appears unjustified given single-digit profit growth, margin compression, and modest long-term growth trajectory. Wait for either significant price correction (below ₹4,900) or clear evidence of sustained growth reacceleration before considering entry.
For Existing Holders: Consider reducing positions or exiting on any bounce towards ₹5,700-5,800 levels. Whilst the company's fundamental quality remains intact with zero debt and strong cash generation, the combination of expensive valuation, deteriorating margins, and negative price momentum creates an unfavourable risk-reward equation. Long-term holders with low cost basis may retain core positions but should book partial profits to reduce exposure.
Fair Value Estimate: ₹4,800 (12% downside from current levels), based on 25x earnings applied to normalised FY27 EPS estimates, factoring in modest growth expectations and margin pressures.
Note: ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. All investments carry risk, including potential loss of principal.
